Nyxoah Secures European Approval For Genio 2.1 Neurostimulation Therapy For Sleep Apnea
[ad_1] The DEKRA Notified Body has approved the use of Nyxoah SA’s NYXH next-generation Genio 2.1 system for patients in Europe. Genio 2.1 is a patient-centered, leadless, and battery-free hypoglossal neurostimulation therapy…